Skip to main content

Table 2 Average dosimetric results for the fourteen patients

From: Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy

Structures

Value

SPArc

RO-IMPT

p value

ITV

D99%(Gy)

66

66

N/A

D1%(Gy)

70.9

71.1

0.22

Total Lung

V5(%)

20.4

25.0

0.001

V10(%)

16.2

20.4

0.001

V20(%)

12.9

16.1

0.001

V30(%)

10.8

13.4

0.001

Mean(Gy)

7.9

9.5

0.001

Cord

D0.03cc(Gy)

17.8

22.4

0.04

Heart

V40(%)

4.4

5.0

0.03

Mean(Gy)

4.2

4.9

0.01

Esophagus

Mean(Gy)

12.9

14.6

0.003

ID

(J)

72.0

77.3

0.001

CI

 

0.70

0.68

0.33

DT (ELST 0.2 s)

(s)

160.1

182.0

0.001

DT (ELST 0.5 s)

(s)

213.8

207.9

0.22

DT (ELST 1 s)

(s)

303.4

250.9

0.001

DT (ELST 2 s)

(s)

482.5

337.1

0.001

DT (ELST 4 s)

(s)

840.8

509.4

0.001

  1. Abbreviations: ITV internal target volume, Cl conformality index, ID integral dose, DT estimated delivery time, ELST energy layer switch time